{
    "hands_on_practices": [
        {
            "introduction": "The primary function of an antacid is to neutralize gastric acid, a property quantified as its Acid Neutralizing Capacity (ANC). This exercise connects fundamental chemistry to clinical pharmacology by asking you to calculate the true ANC of a combination antacid product. By applying principles of stoichiometry and accounting for real-world factors like assay purity and bioavailability, you will gain a foundational understanding of how these essential medicines are evaluated and compared .",
            "id": "4935886",
            "problem": "A patient undergoing Helicobacter pylori (H. pylori) eradication with a proton pump inhibitor plus two antibiotics experiences dyspepsia and intermittently uses an over-the-counter (OTC) combination antacid. The standard dose the patient takes consists of $400\\,\\mathrm{mg}$ of magnesium hydroxide $\\mathrm{Mg(OH)}_{2}$ in a liquid formulation and $750\\,\\mathrm{mg}$ of calcium carbonate $\\mathrm{CaCO}_{3}$ as a chewable tablet. The label claim masses refer to nominal content. An independent in vitro test that mimics gastric conditions (acid in excess, fasted state) reports the following assay fractions and dissolution/availability fractions for the active ingredients: for $\\mathrm{Mg(OH)}_{2}$, assay fraction $0.96$ and availability fraction $0.85$; for $\\mathrm{CaCO}_{3}$, assay fraction $0.98$ and availability fraction $0.95$. Under these conditions, assume the acid is in large excess and the reactions go to completion, with carbon dioxide $\\mathrm{CO}_{2}$ evolving.\n\nStarting from fundamental acid-base principles and stoichiometry, derive the balanced reactions for neutralization of gastric hydrochloric acid (HCl) by $\\mathrm{Mg(OH)}_{2}$ and $\\mathrm{CaCO}_{3}$, deduce the hydrogen ion equivalence per mole of each antacid, and compute the Acid Neutralizing Capacity (ANC) of the standard dose as the total milliequivalents of hydrogen ion neutralized. Use the atomic weights $\\mathrm{Mg}: 24.305$, $\\mathrm{O}: 15.999$, $\\mathrm{H}: 1.008$, $\\mathrm{Ca}: 40.078$, $\\mathrm{C}: 12.011$ to form molar masses. Treat $1\\,\\mathrm{g} = 1000\\,\\mathrm{mg}$ and $1\\,\\mathrm{equiv} = 1000\\,\\mathrm{mEq}$. Round your final ANC to four significant figures. Express the ANC in $\\mathrm{mEq}$ per standard dose.",
            "solution": "The problem is validated as scientifically grounded, well-posed, and objective. It is a direct application of fundamental stoichiometric principles to a realistic scenario in pharmacology. All necessary data are provided, and the constraints are consistent and clear.\n\nThe solution proceeds by first establishing the chemical basis for the neutralization reactions, then calculating the actual amount of reactive substance, and finally determining the total acid neutralizing capacity based on molar equivalences.\n\nFirst, we establish the balanced chemical equations for the neutralization of gastric hydrochloric acid, $\\mathrm{HCl}$, by magnesium hydroxide, $\\mathrm{Mg(OH)}_{2}$, and calcium carbonate, $\\mathrm{CaCO}_{3}$.\n\nFor magnesium hydroxide, the reaction is:\n$$\n\\mathrm{Mg(OH)}_{2} (\\mathrm{s}) + 2 \\mathrm{HCl} (\\mathrm{aq}) \\rightarrow \\mathrm{MgCl}_{2} (\\mathrm{aq}) + 2 \\mathrm{H}_{2}\\mathrm{O} (\\mathrm{l})\n$$\nFrom this stoichiometry, $1$ mole of $\\mathrm{Mg(OH)}_{2}$ neutralizes $2$ moles of hydrochloric acid, which corresponds to $2$ moles of hydrogen ions, $\\mathrm{H}^{+}$. Thus, the equivalence factor for $\\mathrm{Mg(OH)}_{2}$ is $2$ equivalents of $\\mathrm{H}^{+}$ per mole of antacid.\n\nFor calcium carbonate, the reaction is:\n$$\n\\mathrm{CaCO}_{3} (\\mathrm{s}) + 2 \\mathrm{HCl} (\\mathrm{aq}) \\rightarrow \\mathrm{CaCl}_{2} (\\mathrm{aq}) + \\mathrm{H}_{2}\\mathrm{O} (\\mathrm{l}) + \\mathrm{CO}_{2} (\\mathrm{g})\n$$\nSimilarly, $1$ mole of $\\mathrm{CaCO}_{3}$ neutralizes $2$ moles of $\\mathrm{HCl}$, corresponding to $2$ moles of $\\mathrm{H}^{+}$. The equivalence factor for $\\mathrm{CaCO}_{3}$ is also $2$ equivalents of $\\mathrm{H}^{+}$ per mole of antacid.\n\nNext, we calculate the molar masses ($M$) of the active ingredients using the provided atomic weights: $\\mathrm{Mg}: 24.305\\,\\mathrm{g/mol}$, $\\mathrm{O}: 15.999\\,\\mathrm{g/mol}$, $\\mathrm{H}: 1.008\\,\\mathrm{g/mol}$, $\\mathrm{Ca}: 40.078\\,\\mathrm{g/mol}$, and $\\mathrm{C}: 12.011\\,\\mathrm{g/mol}$.\n\nThe molar mass of magnesium hydroxide, $M_{\\mathrm{Mg(OH)}_{2}}$, is:\n$$\nM_{\\mathrm{Mg(OH)}_{2}} = M_{\\mathrm{Mg}} + 2 \\times (M_{\\mathrm{O}} + M_{\\mathrm{H}}) = 24.305 + 2 \\times (15.999 + 1.008) = 58.319\\,\\mathrm{g/mol}\n$$\nThe molar mass of calcium carbonate, $M_{\\mathrm{CaCO}_{3}}$, is:\n$$\nM_{\\mathrm{CaCO}_{3}} = M_{\\mathrm{Ca}} + M_{\\mathrm{C}} + 3 \\times M_{\\mathrm{O}} = 40.078 + 12.011 + 3 \\times 15.999 = 100.086\\,\\mathrm{g/mol}\n$$\nThe problem specifies nominal masses for the standard dose, which must be adjusted by the assay and availability fractions to find the effective mass of each substance available for reaction.\n\nFor $\\mathrm{Mg(OH)}_{2}$, the nominal mass is $m_{\\mathrm{nom, Mg(OH)}_{2}} = 400\\,\\mathrm{mg}$, the assay fraction is $f_{\\mathrm{assay, Mg(OH)}_{2}} = 0.96$, and the availability fraction is $f_{\\mathrm{avail, Mg(OH)}_{2}} = 0.85$. The available mass, $m_{\\mathrm{avail, Mg(OH)}_{2}}$, is:\n$$\nm_{\\mathrm{avail, Mg(OH)}_{2}} = m_{\\mathrm{nom, Mg(OH)}_{2}} \\times f_{\\mathrm{assay, Mg(OH)}_{2}} \\times f_{\\mathrm{avail, Mg(OH)}_{2}} = 400\\,\\mathrm{mg} \\times 0.96 \\times 0.85 = 326.4\\,\\mathrm{mg}\n$$\nFor $\\mathrm{CaCO}_{3}$, the nominal mass is $m_{\\mathrm{nom, CaCO}_{3}} = 750\\,\\mathrm{mg}$, the assay fraction is $f_{\\mathrm{assay, CaCO}_{3}} = 0.98$, and the availability fraction is $f_{\\mathrm{avail, CaCO}_{3}} = 0.95$. The available mass, $m_{\\mathrm{avail, CaCO}_{3}}$, is:\n$$\nm_{\\mathrm{avail, CaCO}_{3}} = m_{\\mathrm{nom, CaCO}_{3}} \\times f_{\\mathrm{assay, CaCO}_{3}} \\times f_{\\mathrm{avail, CaCO}_{3}} = 750\\,\\mathrm{mg} \\times 0.98 \\times 0.95 = 698.25\\,\\mathrm{mg}\n$$\nNow, we convert these available masses to moles ($n$) using the calculated molar masses. We use the conversion $1\\,\\mathrm{g} = 1000\\,\\mathrm{mg}$.\n$$\nn_{\\mathrm{Mg(OH)}_{2}} = \\frac{m_{\\mathrm{avail, Mg(OH)}_{2}}}{M_{\\mathrm{Mg(OH)}_{2}}} = \\frac{326.4\\,\\mathrm{mg} \\times \\frac{1\\,\\mathrm{g}}{1000\\,\\mathrm{mg}}}{58.319\\,\\mathrm{g/mol}} = \\frac{0.3264\\,\\mathrm{g}}{58.319\\,\\mathrm{g/mol}} \\approx 0.0055971\\,\\mathrm{mol}\n$$\n$$\nn_{\\mathrm{CaCO}_{3}} = \\frac{m_{\\mathrm{avail, CaCO}_{3}}}{M_{\\mathrm{CaCO}_{3}}} = \\frac{698.25\\,\\mathrm{mg} \\times \\frac{1\\,\\mathrm{g}}{1000\\,\\mathrm{mg}}}{100.086\\,\\mathrm{g/mol}} = \\frac{0.69825\\,\\mathrm{g}}{100.086\\,\\mathrm{g/mol}} \\approx 0.0069763\\,\\mathrm{mol}\n$$\nThe Acid Neutralizing Capacity (ANC) is the total number of milliequivalents ($\\mathrm{mEq}$) of $\\mathrm{H}^{+}$ neutralized. An equivalent ($\\mathrm{equiv}$) of acid is $1$ mole of $\\mathrm{H}^{+}$. The number of equivalents neutralized by each component is the number of moles multiplied by its equivalence factor.\n\nEquivalents neutralized by $\\mathrm{Mg(OH)}_{2}$:\n$$\n\\mathrm{Eq}_{\\mathrm{Mg(OH)}_{2}} = n_{\\mathrm{Mg(OH)}_{2}} \\times 2\\,\\mathrm{equiv/mol} = \\left(\\frac{0.3264}{58.319}\\right) \\times 2\\,\\mathrm{equiv} \\approx 0.011194\\,\\mathrm{equiv}\n$$\nEquivalents neutralized by $\\mathrm{CaCO}_{3}$:\n$$\n\\mathrm{Eq}_{\\mathrm{CaCO}_{3}} = n_{\\mathrm{CaCO}_{3}} \\times 2\\,\\mathrm{equiv/mol} = \\left(\\frac{0.69825}{100.086}\\right) \\times 2\\,\\mathrm{equiv} \\approx 0.013953\\,\\mathrm{equiv}\n$$\nThe total equivalents neutralized, $\\mathrm{Eq}_{\\mathrm{total}}$, is the sum of the equivalents from both components:\n$$\n\\mathrm{Eq}_{\\mathrm{total}} = \\mathrm{Eq}_{\\mathrm{Mg(OH)}_{2}} + \\mathrm{Eq}_{\\mathrm{CaCO}_{3}} \\approx 0.011194 + 0.013953 = 0.025147\\,\\mathrm{equiv}\n$$\nThe problem requires the ANC in milliequivalents ($\\mathrm{mEq}$), where $1\\,\\mathrm{equiv} = 1000\\,\\mathrm{mEq}$.\n$$\n\\mathrm{ANC} = \\mathrm{Eq}_{\\mathrm{total}} \\times 1000\\,\\mathrm{mEq/equiv}\n$$\nUsing the unrounded intermediate values for higher precision:\n$$\n\\mathrm{ANC} = \\left( \\left(\\frac{0.3264}{58.319}\\right) \\times 2 + \\left(\\frac{0.69825}{100.086}\\right) \\times 2 \\right) \\times 1000 \\approx 25.14688\\,\\mathrm{mEq}\n$$\nRounding the final answer to four significant figures gives:\n$$\n\\mathrm{ANC} \\approx 25.15\\,\\mathrm{mEq}\n$$\nThe calculated ANC represents the total capacity of one standard dose of the antacid combination to neutralize gastric acid under the specified in vitro conditions.",
            "answer": "$$\\boxed{25.15}$$"
        },
        {
            "introduction": "While understanding an antacid's static capacity is crucial, its clinical utility depends on dynamic factors like the rate of acid secretion and the desired duration of action. This practice uses a simplified but powerful model based on mass balance to determine the amount of antacid required to maintain gastric $pH$ above a therapeutic threshold for a specific time. This exercise will help you translate a drug's intrinsic property (ANC) into a rational, goal-oriented dosing calculation, bridging the gap between pharmacodynamics and practical application .",
            "id": "4935896",
            "problem": "A patient with confirmed Helicobacter pylori (H. pylori) infection is to begin a regimen in which maintaining intragastric $pH>4$ for a continuous duration of $t$ hours is desired to enhance the stability of co-administered antibiotics. While acid suppression with a Proton Pump Inhibitor (PPI) is being initiated, an antacid will be used as a bridging strategy. Assume gastric acid secretion occurs at a constant rate of $r$ milliequivalents per hour, starting at time $t=0$ when the gastric lumen has been titrated to $pH=4$ (so that there is negligible free hydrogen ion above the $pH=4$ threshold at $t=0$). Assume no gastric emptying of acid or antacid over the interval of interest, and neglect endogenous buffering other than the administered antacid.\n\nThe antacid’s Acid Neutralizing Capacity (ANC) against hydrochloric acid, measured to a terminal $pH=4$, is $A$ milliequivalents per gram. Use the following base principles:\n- Conservation of mass for strong acid equivalents in the gastric lumen.\n- Stoichiometry of acid–base neutralization, where $1$ equivalent of base neutralizes $1$ equivalent of hydrogen ion.\n- The definition that $1$ milliequivalent corresponds to $10^{-3}$ equivalents.\n\nDerive, from first principles, the expression for the total neutralizing capacity required over the interval to ensure $pH>4$ at all times, and then determine the mass of antacid (in grams) that must be administered to supply this capacity. Express your final results symbolically in terms of $r$, $t$, and $A$. Provide your answers as analytic expressions only; do not substitute numbers. Express the mass in grams. No rounding is required.",
            "solution": "The problem requires the derivation of two quantities from first principles: first, the total acid neutralizing capacity needed to maintain an intragastric $pH > 4$ for a duration $t$, and second, the mass of an antacid required to provide this capacity.\n\n### Step 1: Problem Validation\n\n**Extracted Givens:**\n- Desired condition: Intragastric $pH > 4$.\n- Duration of interest: $t$ hours.\n- Gastric acid secretion rate: $r$ milliequivalents per hour (constant).\n- Initial condition at time $t=0$: $pH=4$.\n- Assumption: No gastric emptying of acid or antacid.\n- Assumption: Neglect of endogenous buffering.\n- Antacid's Acid Neutralizing Capacity (ANC): $A$ milliequivalents per gram, measured to a terminal $pH=4$.\n- Principle: Conservation of mass.\n- Principle: $1$ equivalent of base neutralizes $1$ equivalent of acid.\n- Definition: $1$ milliequivalent $= 10^{-3}$ equivalents.\n\n**Validation Using Extracted Givens:**\n- **Scientific Grounding:** The problem is based on fundamental principles of acid-base chemistry and simplified pharmacokinetic modeling. The concepts of pH, acid secretion rate (in meq/h), and Acid Neutralizing Capacity (ANC) are standard in pharmacology and gastroenterology. The assumptions (constant secretion rate, no emptying) are idealizations common in first-order models to make the problem tractable. They do not violate fundamental scientific laws.\n- **Well-Posedness:** The problem provides a clear objective and sufficient, consistent information to derive a unique solution for the requested quantities ($C_{req}$ and $m$) in terms of the given parameters ($r$, $t$, $A$).\n- **Objectivity:** The problem is stated in precise, quantitative, and unbiased language.\n\n**Verdict:** The problem is valid. It is a well-defined, scientifically grounded problem that can be solved using the principles provided.\n\n### Step 2: Derivation of the Solution\n\nThe solution is derived in two parts as requested: determining the total required neutralizing capacity and then the mass of the antacid.\n\n**Part 1: Derivation of the Total Required Neutralizing Capacity ($C_{req}$)**\n\nThe primary goal is to maintain the intragastric $pH > 4$. At time $t=0$, the system is at $pH=4$. To prevent the pH from falling below this value, any new acid secreted into the stomach must be immediately neutralized.\n\nThe rate of acid secretion is given as a constant, $r$, in units of milliequivalents per hour. Over a time interval of $t$ hours, the total amount of hydrogen ions ($H^+$) secreted into the gastric lumen, denoted as $H^+_{total}$, can be calculated.\nThe amount of a substance produced at a constant rate is the product of the rate and the time duration.\n$$ H^+_{total} = r \\cdot t $$\nThe units of this quantity are $(\\text{milliequivalents}/\\text{hour}) \\times (\\text{hour}) = \\text{milliequivalents}$.\n\nAccording to the principle of stoichiometry for acid-base reactions, one equivalent of a base neutralizes one equivalent of an acid. This relationship holds for any fractional unit, including milliequivalents ($1$ meq of base neutralizes $1$ meq of acid).\n\nTo ensure the $pH$ does not drop below $4$, the total amount of neutralizing agent (base) administered must be sufficient to neutralize the total amount of acid produced during the interval $t$. Therefore, the total required neutralizing capacity, $C_{req}$, must be equal to the total amount of acid secreted, $H^+_{total}$.\n$$ C_{req} = H^+_{total} $$\nSubstituting the expression for $H^+_{total}$, we find:\n$$ C_{req} = rt $$\nThis expression represents the total milliequivalents of base activity required over the duration $t$.\n\n**Part 2: Derivation of the Required Mass of Antacid ($m$)**\n\nThe problem provides the Acid Neutralizing Capacity (ANC) of the specific antacid to be used. This value is given as $A$, with units of milliequivalents per gram. This means that $1$ gram of the antacid can neutralize $A$ milliequivalents of acid.\n\nLet $m$ be the mass of the antacid in grams that must be administered. The total neutralizing capacity provided by this mass is the product of the mass and the ANC per unit mass.\n$$ \\text{Total Capacity Provided} = m \\cdot A $$\nThis provided capacity must be at least equal to the required capacity, $C_{req}$, to meet the therapeutic goal. We set them equal to find the minimum required mass.\n$$ m \\cdot A = C_{req} $$\nSubstituting the expression for $C_{req}$ derived in Part 1:\n$$ m \\cdot A = rt $$\nTo find the mass $m$, we solve this equation for $m$ by dividing both sides by $A$:\n$$ m = \\frac{rt}{A} $$\nThe units for this expression are $(\\text{milliequivalents}) / (\\text{milliequivalents}/\\text{gram}) = \\text{grams}$, which is consistent with the definition of $m$ as a mass.\n\nThus, the two derived expressions are:\n1.  Total neutralizing capacity required: $rt$\n2.  Mass of antacid required: $\\frac{rt}{A}$",
            "answer": "$$\\boxed{\\begin{pmatrix} rt & \\frac{rt}{A} \\end{pmatrix}}$$"
        },
        {
            "introduction": "Antacids are chemically reactive and can significantly interfere with the absorption of other drugs, a critical consideration in polypharmacy, such as in regimens for *Helicobacter pylori*. This problem delves into the mechanism of a common drug-drug interaction—chelation—using a quantitative model based on Langmuir binding kinetics. By deriving the equilibrium concentration of unbound antibiotic in the presence of an antacid, you will learn to predict the impact of this interaction on systemic drug exposure and appreciate the pharmacological basis for staggering medication administration times .",
            "id": "4935863",
            "problem": "A patient on a levofloxacin-containing Helicobacter pylori salvage regimen is self-medicating with an aluminum–magnesium hydroxide antacid. In the gastrointestinal (GI) lumen during the absorption window, assume a single, well-mixed compartment in which levofloxacin (a fluoroquinolone) binds reversibly and non-cooperatively in a $1{:}1$ manner to antacid cation-binding sites, obeying a Langmuir-type equilibrium based on mass action. Let the equilibrium dissociation constant be $K_{d}$ and the total concentration of available binding sites be $S_{T}$. Let the total dissolved levofloxacin concentration be $C_{T}$. Assume only unbound levofloxacin can permeate the epithelium, that equilibrium is reached rapidly relative to absorption, and that systemic clearance and first-pass extraction are unchanged by the antacid. Under linear pharmacokinetics, the oral Area Under the Curve (AUC) is proportional to the fraction of dose absorbed, and the fraction absorbed is proportional to the unbound fraction in the lumen.\n\nStarting from the core definitions of mass action ($K_{d} = \\frac{[D][S]}{[DS]}$ with $[D]$ the free drug, $[S]$ unoccupied sites, and $[DS]$ drug–site complex) and conservation ($S_{T} = [S] + [DS]$ and $C_{T} = [D] + [DS]$), derive the fraction of AUC retained when the antacid is coadministered and then compute the reduction in AUC relative to the antacid-free condition.\n\nUse the following scientifically consistent parameters: $K_{d} = 0.10$ mM, $S_{T} = 0.60$ mM, and $C_{T} = 1.00$ mM. Express the final reduction in AUC as a decimal (no percentage sign) and round your answer to four significant figures. The answer is dimensionless.",
            "solution": "The objective is to calculate the reduction in the Area Under the Curve (AUC), which is stated to be proportional to the unbound fraction of the drug, $f_u = \\frac{[D]}{C_T}$. The reduction in AUC relative to the antacid-free case (where $f_u=1$) is $1 - f_u$. Our primary task is to find the equilibrium concentration of free drug, $[D]$.\n\nThe problem provides the governing relationships for the binding equilibrium:\n1.  Equilibrium dissociation: $K_{d} = \\frac{[D][S]}{[DS]}$\n2.  Conservation of binding sites: $S_{T} = [S] + [DS]$\n3.  Conservation of drug: $C_{T} = [D] + [DS]$\n\nWe can solve this system of equations for $[D]$. First, express $[DS]$ and $[S]$ in terms of $[D]$.\nFrom the conservation of drug equation (3), we get:\n$$[DS] = C_{T} - [D]$$\nFrom the conservation of sites equation (2), we get:\n$$[S] = S_{T} - [DS]$$\nSubstituting the expression for $[DS]$ into the equation for $[S]$:\n$$[S] = S_{T} - (C_{T} - [D]) = S_{T} - C_{T} + [D]$$\n\nNow, we substitute the expressions for $[DS]$ and $[S]$ into the equilibrium equation (1):\n$$K_{d} = \\frac{[D] (S_{T} - C_{T} + [D])}{C_{T} - [D]}$$\nRearranging this equation will yield a quadratic equation for $[D]$:\n$$K_{d} (C_{T} - [D]) = [D] (S_{T} - C_{T} + [D])$$\n$$K_{d} C_{T} - K_{d} [D] = [D]S_{T} - [D]C_{T} + [D]^2$$\n$$0 = [D]^2 + (S_{T} - C_{T} + K_{d})[D] - K_{d}C_{T}$$\n\nThis is a quadratic equation of the form $a[D]^2 + b[D] + c = 0$, where:\n$a = 1$\n$b = S_{T} - C_{T} + K_{d}$\n$c = -K_{d}C_{T}$\n\nWe use the quadratic formula to find $[D]$. Since concentration must be a positive physical quantity, we select the positive root.\n$$[D] = \\frac{-b + \\sqrt{b^2 - 4ac}}{2a} = \\frac{-(S_{T} - C_{T} + K_{d}) + \\sqrt{(S_{T} - C_{T} + K_{d})^2 + 4K_{d}C_{T}}}{2}$$\n\nNow, substitute the given numerical values: $K_{d} = 0.10$ mM, $S_{T} = 0.60$ mM, and $C_{T} = 1.00$ mM.\nFirst, we calculate the term $(S_{T} - C_{T} + K_{d})$:\n$$S_{T} - C_{T} + K_{d} = 0.60 - 1.00 + 0.10 = -0.30 \\text{ mM}$$\nNext, we substitute this into the solution for $[D]$:\n$$[D] = \\frac{-(-0.30) + \\sqrt{(-0.30)^2 + 4(0.10)(1.00)}}{2}$$\n$$[D] = \\frac{0.30 + \\sqrt{0.09 + 0.40}}{2}$$\n$$[D] = \\frac{0.30 + \\sqrt{0.49}}{2}$$\n$$[D] = \\frac{0.30 + 0.70}{2} = \\frac{1.00}{2} = 0.50 \\text{ mM}$$\n\nThe equilibrium concentration of free (unbound) levofloxacin is $[D] = 0.50$ mM.\nThe unbound fraction, $f_u$, is the ratio of free drug to total drug concentration:\n$$f_u = \\frac{[D]}{C_{T}} = \\frac{0.50 \\text{ mM}}{1.00 \\text{ mM}} = 0.50$$\nThe reduction in AUC is calculated as $1 - f_u$:\n$$\\text{Reduction in AUC} = 1 - 0.50 = 0.50$$\nThe problem asks for the answer as a decimal rounded to four significant figures.\n$$\\text{Reduction in AUC} = 0.5000$$",
            "answer": "$$\\boxed{0.5000}$$"
        }
    ]
}